With a market cap of $32.1 billion, Kenvue Inc. (KVUE) is a global consumer health company focused on over-the-counter medicines, personal care, and skin health products. Headquartered in Summit, New Jersey, Kenvue was spun off from Johnson & Johnson (JNJ) in 2023 and owns a portfolio of widely recognized, heritage brands with strong market positions across everyday health categories.
Kenvue is expected to announce its fourth-quarter results soon. Ahead of the event, analysts expect KVUE to report an adjusted EPS of $0.22, down 15.4% from $0.26 reported in the year-ago quarter. On a positive note, the company has a robust earnings surprise history. It has met or surpassed the Street’s bottom-line estimates in each of the past four quarters.
